KRAS and pancreatic intraductal papillary-mucinous neoplasm: The co-occurrence of mutations simultaneously activating Gαs and KRAS is not rare in tumors like IPMN but may be coincidental, perhaps resulting from contamination of samples with cells from two independent origins.